Allarity Therapeutics Files 8-K
Ticker: ALLR · Form: 8-K · Filed: Jun 5, 2025 · CIK: 1860657
Sentiment: neutral
Topics: 8-k, filing
Related Tickers: ALLR
TL;DR
ALLR filed an 8-K on 6/5 for an event on 6/4. Check for details.
AI Summary
Allarity Therapeutics, Inc. filed an 8-K on June 5, 2025, reporting an event that occurred on June 4, 2025. The filing is categorized under 'Other Events' and 'Financial Statements and Exhibits'. The company's principal executive offices are located at 123 E Tarpon Ave, Tarpon Springs, FL 34689.
Why It Matters
This 8-K filing indicates a material event has occurred for Allarity Therapeutics, Inc., requiring public disclosure. Investors should review the filing for details on the nature of the event and its potential impact.
Risk Assessment
Risk Level: low — The filing is a standard 8-K current report, indicating an event occurred, but the specific nature and impact are not detailed in the provided text.
Key Players & Entities
- Allarity Therapeutics, Inc. (company) — Registrant
- June 4, 2025 (date) — Earliest event reported
- June 5, 2025 (date) — Date of report
- 123 E Tarpon Ave, Tarpon Springs, FL 34689 (location) — Principal executive offices
FAQ
What specific event is Allarity Therapeutics, Inc. reporting in this 8-K filing?
The provided text does not specify the exact event, only that it occurred on June 4, 2025, and is categorized under 'Other Events' and 'Financial Statements and Exhibits'.
When was this 8-K filing submitted to the SEC?
The 8-K filing was submitted on June 5, 2025.
What is the principal executive office address for Allarity Therapeutics, Inc.?
The principal executive offices are located at 123 E Tarpon Ave, Tarpon Springs, FL 34689.
What is the Commission File Number for Allarity Therapeutics, Inc.?
The Commission File Number is 001-41160.
What is the Standard Industrial Classification (SIC) code for Allarity Therapeutics, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 5, 2025 regarding Allarity Therapeutics, Inc. (ALLR).